How to treat early symptoms of stomach cancer
In general, early symptoms of gastric cancer mainly include gastrointestinal discomfort, loss of appetite, vomiting, black stools, anemia, etc. Main treatment methods include general supportive care, surgical treatment, chemotherapy, targeted therapy, and immunotherapy. If any abnormalities occur, timely medical consultation is recommended. Specific details are as follows:
1. Early Symptoms of Gastric Cancer
1. Gastrointestinal discomfort: This may manifest as upper abdominal fullness, nausea, acid reflux, belching, etc. These symptoms are often the most common digestive reactions in patients with early-stage gastric cancer.
2. Loss of appetite: Due to impaired digestion and absorption caused by gastric cancer, patients may experience reduced appetite, weight loss, and progressive thinning.
3. Vomiting: If the tumor causes obstruction or disrupts normal stomach function, vomiting may occur.
4. Black stools: When early gastric cancer cells invade blood vessels in the stomach wall, it can lead to upper gastrointestinal bleeding, resulting in black, tarry stools (melena).
5. Anemia: Chronic gastrointestinal bleeding may lead to anemia, presenting as fatigue, weakness, dizziness, blurred vision, etc.
2. Treatment Methods for Early Gastric Cancer
1. General supportive care: In early-stage gastric cancer, attention should be paid to dietary adjustment, regular lifestyle, moderate exercise, and emotional management to promote recovery and improve quality of life.
2. Surgical treatment: This primarily includes endoscopic submucosal resection (ESD). This approach is minimally invasive and allows for rapid recovery, but requires precise preoperative diagnosis to determine the extent and depth of tumor invasion.
3. Chemotherapy: Chemotherapy involves using anticancer drugs such as cisplatin, oxaliplatin, and paclitaxel to kill cancer cells or inhibit their growth. It is primarily used for patients who are not suitable candidates for surgery or as adjuvant therapy following surgery.
4. Targeted therapy: This treatment precisely targets cancer cells by using targeted agents such as trastuzumab, nivolumab, and apatinib, thereby achieving therapeutic effects.
5. Immunotherapy: Immunotherapy serves as an adjunctive treatment that activates the body's immune system to fight cancer. Commonly used drugs include PD-1/PD-L1 inhibitors such as pembrolizumab. This therapy helps restore the body’s normal immune response against cancer cells, thus controlling disease progression.
In addition, patients need regular follow-up examinations to monitor disease changes and promptly detect and manage any potential complications or recurrence.